TitleIssue datePagesPrice[¥]StatusRemark
Guideline for Drug Interactions for Drug Development and Labeling Recommendations [MU001]7/23/20188484,000Downloadable in 7 days
Q&A for "Guideline for Drug Interactions for Drug Development and Labeling Recommendations" [MU002]7/23/20181818,000
Procedure for Manufacturing and Selling DNA Sequencer for Genetic Test System [MU003]4/28/201633,000Downloadable in 7 days
Q&A for "Procedure for Manufacturing and Selling DNA Sequencer for Genetic Test System" [MU004]1/26/201722,000Downloadable in 7 days
Guidance for Environmental Impact Assessment for New Drug Development [MU005]3/30/201677,000Downloadable in 7 days
Guideline for the Development of Liposome Formulation [MU006]3/28/20162222,000Downloadable in 7 days
Q&A for "Guideline for the Development of Liposome Formulation" [MU007]3/28/201633,000Downloadable in 7 days
Reflection Paper for Nano Formulation Loaded with Nucleic Acids (siRNA) [MU008]3/28/20168Free
Guideline for PK/PD of Antibiotics [MU009]12/25/20151717,000Downloadable in 7 days
Guideline on Bioanalytical Method (Ligand Binding Assay) Validation in Pharmaceutical Development [MU010]4/1/201421Free
Q&A for "Guideline on Bioanalytical Method (Ligand Binding Assay) Validation in Pharmaceutical Development" [MU011]4/1/20146Free
Points to Consider When Submitting Market Authorization of In Vitro Diagnostics Classified as Companion Drug, etc. [MU012]3/28/201433,000Downloadable in 7 days
Q&A for "Points to Consider When Submitting Market Authorization of In Vitro Diagnostics Classified as Companion Drug, etc." [MU013]2/19/201433,000Downloadable in 7 days
Joint Reflection Paper for the Development of Block Co-Polymer Micelle Drugs by PMDA and EMA [MU014]1/10/201416Free
Q&A for "Joint Reflection Paper for the Development of Block Co-Polymer Micelle Drugs by PMDA / EMA" [MU015]1/10/20144Free
Technical Guidance for Companion Drugs and Related Pharmaceutical Products [MU016]12/26/201344,000Downloadable in 7 days
Guideline on Bioanalytical Method Validation in Pharmaceutical Development [MU017]7/11/201325Free
Q&A for "Guideline on Bioanalytical Method Validation in Pharmaceutical Development" [MU018]7/11/20135Free
Points to Consider for Market Authorizqtion of Companion Diagnostic Drugs and Related Pharmaceutical Products [MU019]7/1/201344,000Downloadable in 7 days
Q&A for "Points to Consider for Market Authorizqtion of Companion Diagnostic Drugs and Related Pharmaceutical Products" [MU020]7/1/201333,000Downloadable in 7 days
Guidance For Establishing Safety in First-in-Human Studies during Drug Development [MU021]4/2/201221Free
Q&A for "Guidance For Establishing Safety in First-in-Human Studies during Drug Development" [MU022]4/2/20124Free
Guideline for the Development of Prototype Vaccine for the Preparedness for Pandemic Influenza [MU023]10/31/20111010,000Downloadable in 7 days

It seems we can’t find what you’re looking for. Perhaps searching can help.